MOXYLAN 200MG TABLETS BROAD SPECTRUM ANTIBIOTIC

Nazione: Australia

Lingua: inglese

Fonte: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Compra

Foglio illustrativo Foglio illustrativo (PIL)
20-06-2017
Scheda tecnica Scheda tecnica (SPC)
20-06-2017
Scheda di Sicurezza Scheda di Sicurezza (SDS)
01-07-1998

Principio attivo:

AMOXYCILLIN AS AMOXYCILLIN TRIHYDRATE

Commercializzato da:

JUROX PTY LIMITED

INN (Nome Internazionale):

amoxycillin as trihydrate(200mg/Tb)

Forma farmaceutica:

ORAL TABLET

Composizione:

AMOXYCILLIN AS AMOXYCILLIN TRIHYDRATE ANTIBIOTIC Active 200.0 mg/Tb

Confezione:

500 Tabs

Classe:

VM - Veterinary Medicine

Gruppo terapeutico:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Area terapeutica:

ANTIBIOTIC & RELATED

Indicazioni terapeutiche:

ANTIBIOTICS - ORAL, PARENTERAL | AIRSACCULITIS | AMOXYCILLIN SENSITIVE BACTERIA | ANAEROBIC BACTERIAL INFECTION | AVIAN MYCOPLASMAS | CLAVULANIC ACID SENSITIVE | COCCIDIOSIS | CORYZA | CRD | DERMATOSES | DIARRHOEA | ENDOMETRITIS | ENTERITIS | ENZOOTIC PNEUMONIA | ESCHERICHIA COLI | EUROPEAN BROOD DISEASE | GENTAMICIN SENSITIVE | HYPERMOTILITY | INFECTED WOUNDS | INFECTIONS | LACTATING | MASTITIS | PROTOZOAL INFECTIONS | PYOMETRA | SALMONELLOSIS | SINUSITIS | SYSTEMIC BACTERIAL INFECTION

Dettagli prodotto:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [ANTIBIOTICS - ORAL, PARENTERAL]; DOG: [ANTIBIOTICS - ORAL, PARENTERAL]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [ANTIBIOTICS - ORAL, PARENTERAL]; DOG: [ANTIBIOTICS - ORAL, PARENTERAL]; For the treatment of infections caused by amoxycillin susceptible organisms in dogs and cats.Do not administer to small herbivores or animals with a history of allergic reaction to penicillins.

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2023-07-01

Foglio illustrativo

                                Moxylan
200mg
Tablets
label
25/2/98
page l/l
PANEL 1
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
MOXYLAN
200mg
TABLETS
Broad Spectrum Antibiotic
200mg per tablet AMOXYCILLIN as the Trihydrate
,:,
c
N.R.A.
.’
APPROVED
LABEL
For the treatment of infections caused by amoxycillin susceptible
organisms in
dogs and cats.
_JUROX_
500 tablets
PANEL 2
DLRECTLONS FOR USE:
DO NOT ADMINISTER TO SMALL HERBIVORES OR ANIMALS WITH A HISTORY OF
ALLERGIC REACTION TO PENICILLINS.
Dose: 4-l 1
mg/kg body weight twice daily until 48 hours after symptoms have
subsided. For ORAL ADMINISTRATION ONLY.
Prescription Animal Remedy (P.A.R) Class
1,
for use only following a
veterinary consultation.
Licensed under the Animal Remedies Act 1967, No.
Licensed to Jurox New Zealand Limited
51 Shortland St, Auckland, ph/fax 09 236 3915
Made in Australia
Jurox Pty Ltd
Unit 22 Slough Estate, Holker St
Silverwater NSW 2128 AUSTRALIA
Dispose of empty container by wrapping with paper and placing in
garbzge.
Store below 25°C (Air Conditioning) in A DRY PLACE.
0
B
NRA
5060610796
Exp:
C:\REGISTRAWABELS\ANZLABELWOXYL2~L
SAB
MM,
1
                                
                                Leggi il documento completo
                                
                            

Scheda tecnica

                                MOXYLAN TABLETS
Page 1 of 5
continued
ISSUED:
28 AUGUST 2012
SAFETY DATA SHEET
SECTION 1: IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
PRODUCT NAME:
MOXYLAN TABLETS
PRODUCT CODE:
501620 (50mg), 501655 (200mg)
RECOMMENDED USE:
For the treatment of amoxicillin susceptible bacterial infections in
dogs and
cats.
COMPANY IDENTIFICATION:
Jurox Pty Limited
ADDRESS:
85 Gardiner Street
Rutherford NSW 2320
Australia
CUSTOMER CENTRE:
1800 023 312
NATIONAL POISONS INFORMATION CENTRE:
131126 (Australia-wide)
EMERGENCY TELEPHONE NUMBER:
1800 023 312 (9a.m. – 5p.m.)
SECTION 2: HAZARDS IDENTIFICATION
1
GHS HAZARD CLASSIFICATIONS:
EYE IRRITATION CATEGORY 2B
RESPIRATORY SENSITIZER CATEGORY 1
SKIN SENSITIZER CATEGORY 1
STOT – SE CATEGORY 3
GHS PICTOGRAMS:
EXCLAMATION MARK
HEALTH HAZARD
SIGNAL WORD:
DANGER
HAZARD STATEMENTS:
H317
May cause an allergic skin reaction.
H320
Causes eye irritation.
H334
May cause allergy or asthma symptoms or breathing difficulties if
inhaled.
H335
May cause respiratory irritation.
PRECAUTIONARY STATEMENTS:
PREVENTION
P261
Avoid breathing dust and vapours from reconstituted product.
P264
Wash hands thoroughly after handling.
P271
Use only outdoors or in a well-ventilated area.
P272
Contaminated work clothing should not be allowed out of the workplace.
P280
Wear protective gloves e.g. PVC or vinyl and protective eyewear e.g.
Safety
glasses with eye side shields or chemical goggles.
P285
In case of inadequate ventilation wear respiratory protection.
RESPONSE
P302+P352
IF ON SKIN: Wash with plenty of soap and water.
P304+P341
IF INHALED: If breathing is difficult, remove victim to fresh air and
keep at rest in a position comfortable for breathing.
P305+P351
IF IN EYES: Rinse cautiously with water for several minutes.
+P338
Remove contact lenses, if present and easy to do. Continue rinsing.
1
N.B.: These statements are determined by Work Health and Safety
regulations and may not reflect Signal Headings and
First Aid and Safety statements on product labelling, which are
determined by a competent authori
                                
                                Leggi il documento completo
                                
                            

Scheda di Sicurezza

                                WWW.JUROX.COM.AU
Customer Service 1800 023 312
® Registered Trademark of Jurox Pty Limited
TECHNICAL NOTES
ACTIVE CONSTITUENTS
Amoxycillin (as trihydrate) 50 mg/tablet, 200 mg/tablet.
ACTIONS
Amoxycillin is a broad spectrum semisynthetic penicillin which is
bactericidal against a wide range of Gram-positive and
Gram-negative bacterial pathogens, including the following:
_Actinobacillus equuli, Actinobacillus lignieresii, Actinomyces bovis,
_
_Bacillus anthracis, Bordetella _spp_., Clostridium _spp_.,
Corynebacterium _spp_., Erysipelothrix rhusiopathiae, Escherichia
coli, Fusiformis _spp_., _
_Fusobacterium necrophorum, Haemophilus _spp_., Moraxella _spp_.,
Pasteurella _spp_., Proteus mirabilis, Salmonella _spp_.,
Staphylococci_
(excluding penicillin-resistant strains) and _Streptococci._
INDICATIONS
Infections caused by amoxycillin-susceptible organisms in dogs and
cats.
LOCAL INFECTIONS: Dermatitis, abscesses, infected wounds and ear
infections.
GENERAL INFECTIONS: Septicaemia and postparturient infections.
GASTROINTESTINAL TRACT INFECTIONS: Gastroenteritis.
RESPIRATORY TRACT INFECTIONS: Tonsillitis, pharyngitis, bronchitis and
pneumonia.
GENITOURINARY TRACT INFECTIONS: Cystitis, nephritis and metritis. The
high level of antibiotic obtained in urine makes amoxycillin
especially effective in urinary tract infections.
CONTRAINDICATIONS
Administration to small herbivores (e.g. guinea pigs) or animals with
a history of allergic reactions to penicillins.
MOXYLAN
Tablets
WWW.JUROX.COM.AU
Customer Service 1800 023 312
® Registered Trademark of Jurox Pty Limited
TECHNICAL NOTES
DOSAGE AND ADMINISTRATION
Dose: 4 - 11 mg/kg bodyweight twice daily until 48 hours after
symptoms have subsided. For oral administration only.
GHS INFORMATION
For GHS Information see Safety Data Sheet.
PRESENTATION
Tablets, 50 mg, 200 mg: 500s.
STORAGE
Store below 25°C (air conditioning) in a dry place.
POISONS SCHEDULE
S4.
REGISTRATION NUMBERS
APVMA No. 50605 (50 mg), 50606 (200 mg)
AU - Tech Note - Moxylan Tablets / Sep 2018 / APPROVED
                                
                                Leggi il documento completo